What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
Here is an overview of the components and process involved in reconstituting lyophilized peptides: Lyophilized peptides are typically supplied as a dry powder in vials
For this reason, our team has made small test orders from various vendors to determine which offer the highest quality peptides, fastest shipping times, and friendliest service
Tracking information was accurate
(Midi does not prescribe this or other unapproved peptides.) What the science says: The majority of research on Epitalon is from animal studies and small human observational studies, not large, randomized controlled trials
Physician called right away-phone visit was so convenient